Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

KORU Medical Systems, Inc. - Common Stock (NQ:KRMD)

2.820 +0.010 (+0.36%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 89,101
Open 2.830
Bid (Size) 2.820 (3)
Ask (Size) 2.830 (18)
Prev. Close 2.810
Today's Range 2.790 - 2.900
52wk Range 2.050 - 5.050
Shares Outstanding 45,957,115
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Year 2025 Guidance
From KORU Medical Systems, Inc.
Via Business Wire
Earnings Scheduled For March 12, 2025
Via Benzinga

Performance

YTD
-27.4%
-27.4%
1 Month
-23.6%
-23.6%
3 Month
-28.6%
-28.6%
6 Month
+5.2%
+5.2%
1 Year
+28.2%
+28.2%

More News

Read More
Analyst Expectations For KORU Medical Systems's Future
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025
From KORU Medical Systems, Inc.
Via Business Wire
This Informatica Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Via Benzinga
KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology
From KORU Medical Systems
Via Business Wire
KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter
From KORU Medical Systems
Via Business Wire
KORU Medical Systems to Participate in Piper Sandler’s 36th Annual Healthcare Conference
From KORU Medical Systems
Via Business Wire
KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Participate in Upcoming Investor Conferences
From KORU Medical Systems
Via Business Wire
KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery (PODD) Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge® Infusion System over Manual Syringe Administration for Subcutaneous Oncology Infusion
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Report Third Quarter 2024 Financial Results on November 13, 2024
From KORU Medical Systems
Via Business Wire
KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth Conference
From KORU Medical Systems
Via Business Wire
KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference
From KORU Medical Systems
Via Business Wire
KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024
From KORU Medical Systems
Via Business Wire
KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan
From KORU Medical Systems, Inc.
Via Business Wire
Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion
From KORU Medical Systems
Via Business Wire
KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic
From KORU Medical Systems, Inc.
Via Business Wire
KRMD Stock Earnings: KORU Medical Systems Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth
From KORU Medical Systems, Inc.
Via Business Wire

Frequently Asked Questions

Is KORU Medical Systems, Inc. - Common Stock publicly traded?
Yes, KORU Medical Systems, Inc. - Common Stock is publicly traded.
What exchange does KORU Medical Systems, Inc. - Common Stock trade on?
KORU Medical Systems, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for KORU Medical Systems, Inc. - Common Stock?
The ticker symbol for KORU Medical Systems, Inc. - Common Stock is KRMD on the Nasdaq Stock Market
What is the current price of KORU Medical Systems, Inc. - Common Stock?
The current price of KORU Medical Systems, Inc. - Common Stock is 2.820
When was KORU Medical Systems, Inc. - Common Stock last traded?
The last trade of KORU Medical Systems, Inc. - Common Stock was at 03/24/25 04:00 PM ET
What is the market capitalization of KORU Medical Systems, Inc. - Common Stock?
The market capitalization of KORU Medical Systems, Inc. - Common Stock is 129.60M
How many shares of KORU Medical Systems, Inc. - Common Stock are outstanding?
KORU Medical Systems, Inc. - Common Stock has 130M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.